Cipla Ltd - Share Price
CIPLA
Cipla LtdFinancials
Cipla LtdNews & Updates
Cipla gets final USFDA nod for migraine-treatment nasal spray
May 21,2020 01:47 PM
The drug major on Thursday (21 May) said it received final approval for its abbreviated new drug application (ANDA) for Dihydroerg
Cipla's nasal spray gets approval from USFDA for migraine treatment May 21,2020
Cipla receives USFDA final approval for Dihydroergotamine Mesylate Nasal Spray May 21,2020
Cipla's FY20: India biz grows by 12% - All details here! May 18,2020
Investors cheer Cipla despite Q4 PAT decline of 33% to Rs246cr May 18,2020
Cipla files ANDA for generic version of GSK's Advair Diskus; Q4 net profit declines 33% May 18,2020
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 459.15 | 36.04 | 112,576.80 | 468.76 | 0.59 | 2,920.83 | 98.33 |
| Dr Reddys Laboratories Ltd | 3,864.30 | 22.03 | 64,714.06 | 502.80 | 0.64 | 2,837.90 | 914.23 |
| Divis Laboratories Ltd | 2,295.70 | 48.58 | 61,712.15 | 360.73 | 0.69 | 1,390.49 | 266.77 |
| Cipla Ltd | 627.70 | 22.23 | 51,518.69 | 604.57 | 0.63 | 3,042.01 | 215.85 |
| Torrent Pharmaceuticals Ltd | 2,581.55 | 47.06 | 43,995.51 | 220.00 | 0.65 | 1,436.00 | 323.64 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Cipla LtdSummary & Reports
Cipla Ltd is one of the leading pharmaceutical companies in India. The company focuses on development of new formulations and has a wide range of pharmaceutical products. The product portfolio includes over 1,500 products across wide range of therapeutic categories.Cipla Ltd was incorporated in the year 1935 with the name Chemical, Industrial & Pharmaceutical Laboratories Ltd. Khwaja Abdul Hamied, the founder of Cipla gave the company ... More
Registered Office
Cipla House Peninsula Buss Par,Ganpatrao Kadam Mg Lower Parel,Mumbai, Maharashtra,400013
Tell. : +91-22-24826000
Website : http://www.cipla.com
Email : cosecretary@cipla.com
Registrar Office
Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA
Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com
Reports by cipla-ltd
Latest Release by cipla-ltd
IIFLView
Buy - CIPLA
Reco. Price
513.00
May 26, 2020
Target Price
588.00
Target Returns:
14.62%
Result Express
Cipla Ltd's Q2FY19 consolidated net profit declines 10.8% yoy to Rs377.05cr: Misses Estimates
May 26, 2020 04:08 PM
The company’s consolidated revenue in the period stood at Rs4,011.9cr, down 1.73% yoy but up 1.85% qoq.
Shareholding Snapshot
Loading ...
| Mar - 2020 | |
|---|---|
| Promoter | - |
| Foreign | 21.69% |
| Indian | 14.96% |
| Total Promoter | 36.65% |
| Non Promoter | - |
| Institutions | 40.58% |
| Non-Institutions | 22.69% |
| Total Non-Promoter | 63.28% |
| Custodian | 0.07% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
15 May 2020
Annc. Date
09 May 2020
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on... More
Purpose
Dividend
Annc. Date
12 Mar 2020
Effective. Date
19 Mar 2020
Divi. Type
Interim
Divi.(%)
150
Divi. Amt.
3
The Board of Directors of the Company at its meeting held today i.e. 12th March 2020, has approved p... More
Purpose
Dividend
Annc. Date
12 Mar 2020
Effective. Date
19 Mar 2020
Divi. Type
Special
Divi.(%)
50
Divi. Amt.
1
The Board of Directors of the Company at its meeting held today i.e. 12th March 2020, has approved p... More
Purpose
Board Meeting
Exp. Date
12 Mar 2020
Annc. Date
20 Feb 2020
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on... More
